11 Nov, 2026

Breast cancer pill from AstraZeneca misses mark in pivotal study

Andrew covers the biopharma industry, scientific research, and public health across the continent. You can reach Andrew confidentially on Signal at drewqjoseph.71. LONDON — AstraZeneca said Friday that a breast cancer pill failed in a pivotal trial testing it as a first-line therapy in advanced tumors, a result that could limit the use of the […]

2 mins read

Novartis’ experimental cardiovascular drug fails a pivotal study

Andrew covers the biopharma industry, scientific research, and public health across the continent. You can reach Andrew confidentially on Signal at drewqjoseph.71. A closely watched cardiovascular drug from Novartis failed in a pivotal study, the company said Friday, a major blow to the firm and to efforts to target a common heart disease risk factor.  […]

2 mins read

Roche moves obesity drug into pivotal trials after mid-stage success

Andrew Joseph covers health, medicine and the biopharmaceutical industry in Europe. You can reach Andrew on Signal at drawqjoseph.71. Roche plans to launch Phase 3 studies of its lead obesity candidate this quarter after reporting Tuesday that the drug led to significant weight loss in a mid-stage trial. The drug, known as CT-388, caused an […]

1 min read